Literature DB >> 19185813

Foxc2 transcription factor: a newly described regulator of angiogenesis.

Tsutomu Kume1.   

Abstract

Angiogenesis is a critical process to form new blood vessels from preexisting vessels under physiologic and pathologic conditions and involves cellular and morphologic changes such as endothelial cell proliferation, migration, and vascular tube formation. Despite evidence that angiogenic factors, including vascular endothelial growth factor and Notch, control various aspects of angiogenesis, the molecular mechanisms underlying gene regulation in blood vessels and surrounding tissues are not fully understood. Importantly, recent studies demonstrate that Forkhead transcription factor Foxc2 directly regulates expression of various genes involved in angiogenesis, CXCR4, integrin beta3, Delta-like 4 (Dll4), and angiopoietin 2, thereby controlling angiogenic processes. Thus, Foxc2 is now recognized as a novel regulator of vascular formation and remodeling. This review summarizes current knowledge about the function of Foxc2 in angiogenesis and discusses prospects for future research in Foxc2-mediated pathologic angiogenesis in cardiovascular disease.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19185813      PMCID: PMC2674371          DOI: 10.1016/j.tcm.2008.11.003

Source DB:  PubMed          Journal:  Trends Cardiovasc Med        ISSN: 1050-1738            Impact factor:   6.677


  40 in total

1.  Angiopoietin-2 is required for postnatal angiogenesis and lymphatic patterning, and only the latter role is rescued by Angiopoietin-1.

Authors:  Nicholas W Gale; Gavin Thurston; Sean F Hackett; Roumiana Renard; Quan Wang; Joyce McClain; Cliff Martin; Charles Witte; Marlys H Witte; David Jackson; Chitra Suri; Peter A Campochiaro; Stanley J Wiegand; George D Yancopoulos
Journal:  Dev Cell       Date:  2002-09       Impact factor: 12.270

2.  In vitro differentiation of endothelial cells from AC133-positive progenitor cells.

Authors:  U M Gehling; S Ergün; U Schumacher; C Wagener; K Pantel; M Otte; G Schuch; P Schafhausen; T Mende; N Kilic; K Kluge; B Schäfer; D K Hossfeld; W Fiedler
Journal:  Blood       Date:  2000-05-15       Impact factor: 22.113

3.  The murine winged helix transcription factors, Foxc1 and Foxc2, are both required for cardiovascular development and somitogenesis.

Authors:  T Kume; H Jiang; J M Topczewska; B L Hogan
Journal:  Genes Dev       Date:  2001-09-15       Impact factor: 11.361

4.  Roles for the winged helix transcription factors MF1 and MFH1 in cardiovascular development revealed by nonallelic noncomplementation of null alleles.

Authors:  G E Winnier; T Kume; K Deng; R Rogers; J Bundy; C Raines; M A Walter; B L Hogan; S J Conway
Journal:  Dev Biol       Date:  1999-09-15       Impact factor: 3.582

5.  Mutations in FOXC2 (MFH-1), a forkhead family transcription factor, are responsible for the hereditary lymphedema-distichiasis syndrome.

Authors:  J Fang; S L Dagenais; R P Erickson; M F Arlt; M W Glynn; J L Gorski; L H Seaver; T W Glover
Journal:  Am J Hum Genet       Date:  2000-11-08       Impact factor: 11.025

6.  FOXC2 haploinsufficient mice are a model for human autosomal dominant lymphedema-distichiasis syndrome.

Authors:  Benjamin M Kriederman; Teressa L Myloyde; Marlys H Witte; Susan L Dagenais; Charles L Witte; Margaret Rennels; Michael J Bernas; Michelle T Lynch; Robert P Erickson; Mark S Caulder; Naoyuki Miura; David Jackson; Brian P Brooks; Thomas W Glover
Journal:  Hum Mol Genet       Date:  2003-05-15       Impact factor: 6.150

7.  Essential roles of the winged helix transcription factor MFH-1 in aortic arch patterning and skeletogenesis.

Authors:  K Iida; H Koseki; H Kakinuma; N Kato; Y Mizutani-Koseki; H Ohuchi; H Yoshioka; S Noji; K Kawamura; Y Kataoka; F Ueno; M Taniguchi; N Yoshida; T Sugiyama; N Miura
Journal:  Development       Date:  1997-11       Impact factor: 6.868

8.  Defective valves and abnormal mural cell recruitment underlie lymphatic vascular failure in lymphedema distichiasis.

Authors:  Tatiana V Petrova; Terhi Karpanen; Camilla Norrmén; Russell Mellor; Tomoki Tamakoshi; David Finegold; Robert Ferrell; Dontscho Kerjaschki; Peter Mortimer; Seppo Ylä-Herttuala; Naoyuki Miura; Kari Alitalo
Journal:  Nat Med       Date:  2004-08-22       Impact factor: 53.440

9.  Foxc2 is expressed in developing lymphatic vessels and other tissues associated with lymphedema-distichiasis syndrome.

Authors:  Susan L Dagenais; Rebecca L Hartsough; Robert P Erickson; Marlys H Witte; Matthew G Butler; Thomas W Glover
Journal:  Gene Expr Patterns       Date:  2004-10       Impact factor: 1.224

Review 10.  Angiopoietins in tumours: the angiogenic switch.

Authors:  Catherine R Tait; Pamela F Jones
Journal:  J Pathol       Date:  2004-09       Impact factor: 7.996

View more
  28 in total

1.  Small ubiquitin-like modifier (SUMO) modification mediates function of the inhibitory domains of developmental regulators FOXC1 and FOXC2.

Authors:  Theodora E Danciu; Sergey Chupreta; Osvaldo Cruz; Jennifer E Fox; Malcolm Whitman; Jorge A Iñiguez-Lluhí
Journal:  J Biol Chem       Date:  2012-04-05       Impact factor: 5.157

2.  Gastrointestinal lymphatics in health and disease.

Authors:  J S Alexander; Vijay C Ganta; P A Jordan; Marlys H Witte
Journal:  Pathophysiology       Date:  2010-09

3.  LncRNA-MALAT1 as a novel biomarker of cadmium toxicity regulates cell proliferation and apoptosis.

Authors:  Qinhai Huang; Qian Lu; Baoxin Chen; Huanyu Shen; Qun Liu; Zhiheng Zhou; Yixiong Lei
Journal:  Toxicol Res (Camb)       Date:  2017-03-17       Impact factor: 3.524

4.  Transcriptomic changes in the prefrontal cortex of rats as a function of age and cognitive engagement.

Authors:  Michael R Duggan; Surbhi Joshi; Yin-Fei Tan; Michael Slifker; Eric A Ross; Mathieu Wimmer; Vinay Parikh
Journal:  Neurobiol Learn Mem       Date:  2019-06-08       Impact factor: 2.877

5.  Downregulation of Foxc2 enhances apoptosis induced by 5-fluorouracil through activation of MAPK and AKT pathways in colorectal cancer.

Authors:  Chao Yang; Xiaoxian Cui; Xiaoqin Dai; Wenting Liao
Journal:  Oncol Lett       Date:  2016-01-08       Impact factor: 2.967

6.  Identification and initial functional characterization of a human vascular cell-enriched long noncoding RNA.

Authors:  Robert D Bell; Xiaochun Long; Mingyan Lin; Jan H Bergmann; Vivek Nanda; Sarah L Cowan; Qian Zhou; Yu Han; David L Spector; Deyou Zheng; Joseph M Miano
Journal:  Arterioscler Thromb Vasc Biol       Date:  2014-02-27       Impact factor: 8.311

7.  An integrated understanding of the physiological response to elevated extracellular phosphate.

Authors:  Corinne E Camalier; Ming Yi; Li-Rong Yu; Brian L Hood; Kelly A Conrads; Young Jae Lee; Yiming Lin; Laura M Garneys; Gary F Bouloux; Matthew R Young; Timothy D Veenstra; Robert M Stephens; Nancy H Colburn; Thomas P Conrads; George R Beck
Journal:  J Cell Physiol       Date:  2013-07       Impact factor: 6.384

8.  Forkhead box protein C2 contributes to invasion and metastasis of extrahepatic cholangiocarcinoma, resulting in a poor prognosis.

Authors:  Akira Watanabe; Hideki Suzuki; Takehiko Yokobori; Bolag Altan; Norio Kubo; Kenichiro Araki; Satoshi Wada; Yasushi Mochida; Shigeru Sasaki; Kenji Kashiwabara; Yasuo Hosouchi; Hiroyuki Kuwano
Journal:  Cancer Sci       Date:  2013-09-15       Impact factor: 6.716

9.  The Foxc2 transcription factor regulates tumor angiogenesis.

Authors:  Hideto Sano; Jared P Leboeuf; Sergey V Novitskiy; Seungwoon Seo; Snjezana Zaja-Milatovic; Mikhail M Dikov; Tsutomu Kume
Journal:  Biochem Biophys Res Commun       Date:  2010-01-12       Impact factor: 3.575

10.  Overexpression of forkhead Box C2 promotes tumor metastasis and indicates poor prognosis in colon cancer via regulating epithelial-mesenchymal transition.

Authors:  Qingguo Li; Jitao Wu; Ping Wei; Ye Xu; Changhua Zhuo; Yuwei Wang; Dawei Li; Sanjun Cai
Journal:  Am J Cancer Res       Date:  2015-05-15       Impact factor: 6.166

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.